Abstract
Novel Treatments for Thymoma and Thymic Carcinoma.
Highlights
The rarity of thymic epithelial tumors (TETs) creates unique challenges in conducting translational research and developing newer paradigms of treatment [1]
Steady progress in genome research, the development of thymic cell lines, and an increase in collaborative efforts between various institutions have helped in fostering an increase in the understanding of the biology of TETs and associated paraneoplastic syndromes and given an impetus to the development of newer treatment options for patients with these rare tumors
A specific mutation in GTF2I on chromosome 7 is present at a high frequency in World Health Organization (WHO) subtype A and AB thymomas [4]
Summary
The rarity of thymic epithelial tumors (TETs) creates unique challenges in conducting translational research and developing newer paradigms of treatment [1]. (2015) Novel Treatments for Thymoma and Thymic Carcinoma.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
